Form 4: Agilon Health Chief Accounting Officer Reports Routine Stock Withholding for Tax Obligations

Timothy Gertsch, Chief Accounting Officer of agilon health, inc., reported the withholding of 193 shares of common stock valued at $2.22 per share to cover tax obligations related to restricted stock unit vesting.

Summary

• Timothy Gertsch, Chief Accounting Officer of agilon health, inc. (AGL), reported a transaction on May 24, 2025.
• The transaction involved the disposition of 193 shares of Common Stock at a price of $2.22 per share.
• This disposition was not a sale but represented shares withheld by the issuer to satisfy income tax withholding and remittance obligations related to the net settlement of restricted stock units.
• Following this transaction, Mr. Gertsch beneficially owns 115,158 shares, which include restricted stock units.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding related to executive compensation, indicating neither positive nor negative sentiment for the company's operational or financial performance.

Positives

• The transaction indicates the vesting of restricted stock units, which is a common form of executive compensation and can be viewed as a positive for employee retention and alignment of interests.

Negatives

• No direct negatives are identified from this routine tax withholding transaction.

Risks

• No specific risks are detailed in this Form 4 filing.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction, specifically a tax withholding related to executive compensation. It does not provide information relevant to broader industry trends or competitive analysis within the healthcare or managed care sectors.

Comparison to Industry Standards

• This document, being a routine Form 4 filing for tax withholding, does not provide information that allows for a direct comparison to global benchmarks, specific comparable companies, projects, or results in terms of financial performance or operational metrics. Such comparisons are typically made using financial statements (e.g., 10-K, 10-Q) or earnings reports.

Related Party Transactions

• The transaction involves an insider (Chief Accounting Officer Timothy Gertsch) and the issuer (agilon health, inc.) for the purpose of satisfying tax obligations related to restricted stock unit vesting, which is a standard compensation-related dealing.

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a small, routine transaction for tax purposes, not a market sale.
• Employees: Reflects standard executive compensation practices, potentially reinforcing retention.
• Customers, Suppliers, Creditors: No direct impact from this type of filing.

Next Steps

• This Form 4 filing does not outline any specific future actions, events, or milestones for the company or the reporting person beyond the reported transaction.

Key Dates

Keywords

agilon health, AGL, Form 4, insider transaction, stock withholding, restricted stock units, executive compensation, Timothy Gertsch, Chief Accounting Officer, SEC filing